The medical devices sector is typified by frequent change and innovation, in response to problems and issues faced by the healthcare industry. As a result, the sector has seen the emergence of several start-up medtech companies offering disruptive, cutting-edge solutions. Most of these are private companies, where data such as revenue is frequently not disclosed. National estimates for Mirus Bio sales in the US from 2017 to 2023, as well as year-on-year growth rates, can be viewed in GlobalData’s micro revenue report. Buy the report here.
Smarter leaders trust GlobalData
Mirus Bio LLC (Mirus) is a provider of transfection products and also offers reagents for gene therapy, recombinant protein and stem cell applications. The company’s products include transfection reagents and kits, electroporation products and labeling and modifying kits. It markets its products under the brand name of TransIT, CHOgro, Ingenio and Label IT. Mirus’s applications include GMP AAV transfection, virus production, antibody and protein production, CRISPR and CAS genome editing, stem cell transfection, RNAi gene silencing, mRNA and viral RNA transfection, stable cell line generation, low toxicity transfection, co-transfection and electroporation. Mirus is headquartered in Madison, Wisconsin, the US.
The key metrics of Mirus Bio related to marketed and pipeline products, ongoing clinical trials, active jobs and publications from 2023 are shown below:
As Mirus Bio is a privately held company, it is not required to disclose its financial information and there is no stock listed on an exchange. GlobalData has access to a proprietary data set containing invoice data from over 2,600 healthcare institutions in the US and is therefore able to use estimations of a company’s revenue and growth to value private companies such as Mirus Bio.
For a detailed understanding of the performance of Mirus Bio, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.
GlobalData’s revenue report leverages GlobalData’s SKU tracker, which contains real-world, purchasing data from the US healthcare institutions.
